| ACS | Acute coronary syndrome |
| ADP | Adenosine diphosphate |
| ALI | Acute lung injury |
| APC | Antigen-presenting cells |
| ApoE | Apolipoprotein E |
| ARDS | Acute respiratory distress syndrome |
| ATP | Adenosine triphosphate |
| CAD | Coronary artery disease |
| cAMP | Cyclic adenosine monophosphate |
| CD40 | Cluster of differentiation 40 |
| COX | Cyclooxygenase |
| CREKA | Tumor-homing peptide Cys-Arg-Glu-Lys-Ala |
| CRP | C-reactive protein |
| CYP450 | Cytochrome P450 |
| DC | Dendritic cells |
| EL | Extracellular loop |
| ENT-1 | Equilibrative nucleoside transporter 1 |
| FDA | Food and Drug Administration |
| Gi | G-protein i |
| G-protein | Guanine nucleotide-binding protein |
| Gq | G-protein q |
| GPIIbIIIa | Glycoprotein αIIbβ3 |
| HMGB1 | High-mobility group box 1 |
| IL | Interleukin |
| IP3 | Inositol 1,4,5-trisphosphate |
| LPS | Lipopolysaccharide |
| MACE | Major adverse cardiovascular event |
| MCP-1 | Monocyte chemoattractant protein 1 |
| NETs | Neutrophil extracellular traps |
| PAR | Protease-activated receptors |
| PCI | Percutaneous coronary intervention |
| PDGF | Platelet-derived growth factor |
| PF4 | Platelet factor 4 |
| PI3K | Phosphoinositide-3-kinase |
| PKA | Protein kinase A |
| PLAs | Platelet leukocyte aggregates |
| RANTES | Regulated on activation, normal T-cell-expressed and -secreted |
| ROS | Reactive oxygen species |
| TCIPA | Tumor-cell-induced platelet activation |
| TF | Tissue factor |
| TGF | Transforming growth factor |
| TME | Tumor microenvironment |
| TNF | Tumor necrosis factor |
| TXA2 | Thromboxane A2 |
| VASP | Vasodilator-stimulated phosphoprotein |
| VEGF | Vascular endothelial growth factor |
| VSCMs | Vascular smooth muscle cells |